NVIDIA Launches AI Computing Platform for Medical Devices and Computational Sensing Systems

Clara Holoscan MGX Medical-Grade Platform With NVIDIA Orin and NVIDIA AI Software Stack Powers Systems Built by Embedded-Computing Leaders
NVIDIA Launches AI Computing Platform for Medical Devices and Computational Sensing Systems

About NVIDIA
NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market and has redefined modern computer graphics, high performance computing and artificial intelligence. The company’s pioneering work in accelerated computing and AI is reshaping trillion-dollar industries, such as transportation, healthcare and manufacturing, and fueling the growth of many others. More information at https://nvidianews.nvidia.com/.

Certain statements in this press release including, but not limited to, statements as to: the benefits, impact, and performance of our products and technologies, including Clara Holoscan MGX, the Clara Holoscan platform, NVIDIA Jetson AGX Orin, NVIDIA RTX A6000 GPU and NVIDIA ConnectX-7 SmartNIC; deploying real-time AI in healthcare and life sciences being critical to enable the next frontiers in surgery, diagnostics and drug discovery; embedded-computing manufacturers building products based on the Clara Holoscan MGX reference design; and the next generation of software-defined instruments are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2022 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, AGX Orin, ConnectX, DGX, GPUDirect, NVIDIA Clara Holoscan MGX and NVIDIA RTX are trademarks and/or registered trademarks of NVIDIA Corporation and/or Mellanox Technologies in the U.S. and other countries. All other trademarks and copyrights are the property of their respective owners. Features, pricing, availability, and specifications are subject to change without notice.

About NVIDIA
NVIDIA’s (NASDAQ: NVDA) invention of the GPU in 1999 sparked the growth of the PC gaming market and has redefined modern computer graphics, high performance computing and artificial intelligence. The company’s pioneering work in accelerated computing and AI is reshaping trillion-dollar industries, such as transportation, healthcare and manufacturing, and fueling the growth of many others. More information at https://nvidianews.nvidia.com/.

Certain statements in this press release including, but not limited to, statements as to: the benefits, impact, and performance of our products and technologies, including Clara Holoscan MGX, the Clara Holoscan platform, NVIDIA Jetson AGX Orin, NVIDIA RTX A6000 GPU and NVIDIA ConnectX-7 SmartNIC; deploying real-time AI in healthcare and life sciences being critical to enable the next frontiers in surgery, diagnostics and drug discovery; embedded-computing manufacturers building products based on the Clara Holoscan MGX reference design; and the next generation of software-defined instruments are forward-looking statements that are subject to risks and uncertainties that could cause results to be materially different than expectations. Important factors that could cause actual results to differ materially include: global economic conditions; our reliance on third parties to manufacture, assemble, package and test our products; the impact of technological development and competition; development of new products and technologies or enhancements to our existing product and technologies; market acceptance of our products or our partners’ products; design, manufacturing or software defects; changes in consumer preferences or demands; changes in industry standards and interfaces; unexpected loss of performance of our products or technologies when integrated into systems; as well as other factors detailed from time to time in the most recent reports NVIDIA files with the Securities and Exchange Commission, or SEC, including, but not limited to, its annual report on Form 10-K and quarterly reports on Form 10-Q. Copies of reports filed with the SEC are posted on the company’s website and are available from NVIDIA without charge. These forward-looking statements are not guarantees of future performance and speak only as of the date hereof, and, except as required by law, NVIDIA disclaims any obligation to update these forward-looking statements to reflect future events or circumstances.

© 2022 NVIDIA Corporation. All rights reserved. NVIDIA, the NVIDIA logo, AGX Orin, ConnectX, DGX, GPUDirect, NVIDIA Clara Holoscan MGX and NVIDIA RTX are trademarks and/or registered trademarks of NVIDIA Corporation and/or Mellanox Technologies in the U.S. and other countries. All other trademarks and copyrights are the property of their respective owners. Features, pricing, availability, and specifications are subject to change without notice.

Media Contacts

Global contacts for media inquiries.

All Contacts

Stay Informed

Newsroom updates delivered to your inbox.

Subscribe